Written questions, answers and statements

Allergies: Medical Treatments

Show full question

Question for Department of Health and Social Care

UIN 22696, tabled on 8 January 2025

Question

Alicia Kearns
Conservative
Rutland and Stamford
Commons

To ask the Secretary of State for Health and Social Care, when the new Neffy treatment for severe allergic reactions will be available on the NHS.

Answer

Karin Smyth
Labour
Bristol South
Commons

Answered on

14 January 2025

It is critical that medicines used in the United Kingdom are safe and effective. The Medicines and Healthcare products Regulatory Agency (MHRA) assesses all medicines before they can be used in the UK. Neffy (epinephrine nasal spray) has not been licenced by the MHRA. Should an application for it be received, the MHRA will consider the benefit-risk of the product accordingly in regards to its quality, safety and effectiveness. It is the responsibility of the company to apply to the MHRA for a marketing authorisation.

Local National Health Service organisations are expected to make decisions on the availability of medicines based on an assessment of the available evidence and taking into account any relevant national guidance.

Answered by

Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.